These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15779356)

  • 1. [Impaired hepatic glucose metabolism].
    Tamura Y; Sato F
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():131-5. PubMed ID: 15779356
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postprandial hyperglycemia].
    Uchino H; Kawamori R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():147-50. PubMed ID: 15779359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impaired glucose tolerance in chronic liver disease].
    Suzuki K; Kuwayama H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():288-90. PubMed ID: 15779389
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
    Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic characteristics of glucose intolerance: the critical role of obesity.
    Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity.
    Neyrinck AM; Cani PD; Dewulf EM; De Backer F; Bindels LB; Delzenne NM
    Biochem Biophys Res Commun; 2009 Jul; 385(3):351-6. PubMed ID: 19463788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impaired glucose tolerance in liver and pancreas disease].
    Nagasaka Y; Kaneko T
    Nihon Rinsho; 1996 Oct; 54(10):2720-4. PubMed ID: 8914434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
    Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
    Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glucose intolerance: postprandial hyper glucose, risk factor for diabetic macroangiopathy].
    Igarashi Y; Kawamori R
    Nihon Rinsho; 2006 Nov; 64(11):1998-2004. PubMed ID: 17087289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A free-choice high-fat high-sugar diet induces glucose intolerance and insulin unresponsiveness to a glucose load not explained by obesity.
    la Fleur SE; Luijendijk MC; van Rozen AJ; Kalsbeek A; Adan RA
    Int J Obes (Lond); 2011 Apr; 35(4):595-604. PubMed ID: 20714332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
    Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
    Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucose tolerance abnormality in simple obesity].
    Kataoka K; Katsukawa F; Nishino M
    Nihon Rinsho; 1991 Feb; 49 Suppl():647-52. PubMed ID: 2033862
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis of glucose intolerance in alcoholics].
    Ishii H; Ito D
    Nihon Rinsho; 1996 Oct; 54(10):2733-8. PubMed ID: 8914436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats.
    Fujita Y; Kojima H; Hidaka H; Fujimiya M; Kashiwagi A; Kikkawa R
    Diabetologia; 1998 Dec; 41(12):1459-66. PubMed ID: 9867213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action.
    Sheng L; Zhou Y; Chen Z; Ren D; Cho KW; Jiang L; Shen H; Sasaki Y; Rui L
    Nat Med; 2012 Jun; 18(6):943-9. PubMed ID: 22581287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, insulin resistance and hepatic perfusion.
    Brock RW; Dorman RB
    Microcirculation; 2007; 14(4-5):339-47. PubMed ID: 17613806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of visceral fat syndrome in pathogenesis of impaired glucose tolerance].
    Nakamura T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():246-9. PubMed ID: 15779380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.